Factors associated with treatment in primary versus specialist care: A population‐based study of people with type 2 and type 1 diabetes
Open Access
- 8 April 2021
- journal article
- research article
- Published by Wiley in Diabetic Medicine
- Vol. 38 (7) , e14580
Abstract
Aims: The objectives of this study are to identify the proportion and characteristics of people with type 1 and 2 diabetes treated in primary, specialist and shared care and to identify the proportion of persons with type 2 diabetes reaching HbA1c treatment targets and the clinical risk factors and general practitioner and practice characteristics associated with treatment in specialist care.Methods: Population‐based cross‐sectional study including all adults ≥18 years diagnosed with diabetes in primary and specialist care in Salten, Norway. We used multivariable mixed‐effects logistic regression models with level of care as outcome variable and population, general practitioner, and practice characteristics as exposure variables.Results: Of 2704 people with type 2 diabetes, 13.5% were treated in shared care and 2.1% in specialist care only. Of 305 people with type 1 diabetes, 14.4% received treatment in primary care only. The HbA1c treatment target of 53 mmol/mol (7.0%) was reached by 67.3% of people with type 2 diabetes in primary care versus 30.4% in specialist care. HbA1c, use of insulin, coronary heart disease, retinopathy and urban practice location were positively associated with treatment in specialist care. General practitioners’ use of a structured form and a diabetes nurse were negatively associated with specialist care.Conclusions: Of people with type 2 diabetes, 16% were treated in specialist care. They had higher HbA1c and more vascular complications, as expected from priority guidelines. The use of a structured diabetes form and diabetes nurses seem to support type 2 diabetes follow‐up in primary care.Keywords
Funding Information
- Eli Lilly and Company
- Universitetet i Stavanger
- Boehringer Ingelheim
- Merck Sharp and Dohme United Kingdom
- Universitetet i Oslo
- Diabetesforbundet
- Helse Nord RHF
- Sanofi
- Novo Nordisk
- AstraZeneca
This publication has 25 references indexed in Scilit:
- The total prevalence of diagnosed diabetes and the quality of diabetes care for the adult population in Salten, NorwayScandinavian Journal of Public Health, 2020
- Socioeconomic inequalities and type 2 diabetes complications: A systematic reviewDiabetes & Metabolism, 2020
- IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045Diabetes Research and Clinical Practice, 2018
- Type 2 diabetes in general practice in Norway 2005–2014: moderate improvements in risk factor control but still major gaps in complication screeningBMJ Open Diabetes Research & Care, 2017
- Quality of Care of People With Type 2 Diabetes in Eight European CountriesDiabetes Care, 2013
- Effect of a Multifactorial Intervention on Mortality in Type 2 DiabetesNew England Journal of Medicine, 2008
- Medication Taking and DiabetesThe Diabetes Educator, 2007
- Differences in treatment regimes, consultation frequency and referral patterns of diabetes mellitus in general practice in five European countriesFamily Practice, 2004
- Socioeconomic Position and Health among Persons with Diabetes Mellitus: A Conceptual Framework and Review of the LiteratureEpidemiologic Reviews, 2004
- Subspecialist Care Improves Diabetes OutcomesDiabetes Care, 2002